276 related articles for article (PubMed ID: 22138459)
1. Adaptive radiotherapy for head-and-neck cancer: initial clinical outcomes from a prospective trial.
Schwartz DL; Garden AS; Thomas J; Chen Y; Zhang Y; Lewin J; Chambers MS; Dong L
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):986-93. PubMed ID: 22138459
[TBL] [Abstract][Full Text] [Related]
2. Candidate dosimetric predictors of long-term swallowing dysfunction after oropharyngeal intensity-modulated radiotherapy.
Schwartz DL; Hutcheson K; Barringer D; Tucker SL; Kies M; Holsinger FC; Ang KK; Morrison WH; Rosenthal DI; Garden AS; Dong L; Lewin JS
Int J Radiat Oncol Biol Phys; 2010 Dec; 78(5):1356-65. PubMed ID: 20646872
[TBL] [Abstract][Full Text] [Related]
3. Dose uncertainties in IMPT for oropharyngeal cancer in the presence of anatomical, range, and setup errors.
Kraan AC; van de Water S; Teguh DN; Al-Mamgani A; Madden T; Kooy HM; Heijmen BJ; Hoogeman MS
Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):888-96. PubMed ID: 24351409
[TBL] [Abstract][Full Text] [Related]
4. Patterns of disease recurrence following treatment of oropharyngeal cancer with intensity modulated radiation therapy.
Garden AS; Dong L; Morrison WH; Stugis EM; Glisson BS; Frank SJ; Beadle BM; Gunn GB; Schwartz DL; Kies MS; Weber RS; Ang KK; Rosenthal DI
Int J Radiat Oncol Biol Phys; 2013 Mar; 85(4):941-7. PubMed ID: 22975604
[TBL] [Abstract][Full Text] [Related]
5. Parotid glands dose-effect relationships based on their actually delivered doses: implications for adaptive replanning in radiation therapy of head-and-neck cancer.
Hunter KU; Fernandes LL; Vineberg KA; McShan D; Antonuk AE; Cornwall C; Feng M; Schipper MJ; Balter JM; Eisbruch A
Int J Radiat Oncol Biol Phys; 2013 Nov; 87(4):676-82. PubMed ID: 24035328
[TBL] [Abstract][Full Text] [Related]
6. Intensity-modulated radiation therapy for oropharyngeal carcinoma: impact of tumor volume.
Chao KS; Ozyigit G; Blanco AI; Thorstad WL; Deasy JO; Haughey BH; Spector GJ; Sessions DG
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):43-50. PubMed ID: 15093897
[TBL] [Abstract][Full Text] [Related]
7. Monitoring dosimetric impact of weight loss with kilovoltage (kV) cone beam CT (CBCT) during parotid-sparing IMRT and concurrent chemotherapy.
Ho KF; Marchant T; Moore C; Webster G; Rowbottom C; Penington H; Lee L; Yap B; Sykes A; Slevin N
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):e375-82. PubMed ID: 22197229
[TBL] [Abstract][Full Text] [Related]
8. End of treatment cone-beam computed tomography (CBCT) is predictive of radiation response and overall survival in oropharyngeal squamous cell carcinoma.
Sumner W; Kim SS; Vitzthum L; Moore K; Atwood T; Murphy J; Miyauchi S; Califano JA; Mell LK; Mundt AJ; Sharabi AB
Radiat Oncol; 2021 Aug; 16(1):147. PubMed ID: 34372887
[TBL] [Abstract][Full Text] [Related]
9. Volumetric staging in oropharyngeal cancer patients treated with definitive IMRT.
Studer G; Glanzmann C
Oral Oncol; 2013 Mar; 49(3):269-76. PubMed ID: 23089460
[TBL] [Abstract][Full Text] [Related]
10. Unilateral radiotherapy for the treatment of tonsil cancer.
Chronowski GM; Garden AS; Morrison WH; Frank SJ; Schwartz DL; Shah SJ; Beadle BM; Gunn GB; Kupferman ME; Ang KK; Rosenthal DI
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):204-9. PubMed ID: 22019242
[TBL] [Abstract][Full Text] [Related]
11. Near Real-Time Assessment of Anatomic and Dosimetric Variations for Head and Neck Radiation Therapy via Graphics Processing Unit-based Dose Deformation Framework.
Qi XS; Santhanam A; Neylon J; Min Y; Armstrong T; Sheng K; Staton RJ; Pukala J; Pham A; Low DA; Lee SP; Steinberg M; Manon R; Chen AM; Kupelian P
Int J Radiat Oncol Biol Phys; 2015 Jun; 92(2):415-22. PubMed ID: 25847607
[TBL] [Abstract][Full Text] [Related]
12. Adaptive radiotherapy in head and neck cancer is required to avoid tumor underdose.
Castelli J; Simon A; Rigaud B; Chajon E; Thariat J; Benezery K; Vauleon E; Jegoux F; Henry O; Lafond C; de Crevoisier R
Acta Oncol; 2018 Sep; 57(9):1267-1270. PubMed ID: 29706107
[No Abstract] [Full Text] [Related]
13. Repeat CT imaging and replanning during the course of IMRT for head-and-neck cancer.
Hansen EK; Bucci MK; Quivey JM; Weinberg V; Xia P
Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):355-62. PubMed ID: 16256277
[TBL] [Abstract][Full Text] [Related]
14. Adaptive planning in intensity-modulated radiation therapy for head and neck cancers: single-institution experience and clinical implications.
Ahn PH; Chen CC; Ahn AI; Hong L; Scripes PG; Shen J; Lee CC; Miller E; Kalnicki S; Garg MK
Int J Radiat Oncol Biol Phys; 2011 Jul; 80(3):677-85. PubMed ID: 20619553
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of dosimetric and volumetric changes in target volumes and organs at risk during adaptive radiotherapy in head and neck cancer: A prospective study.
Chophy A; Gupta S; Singh P; Sharma N; Krishnan AS; Namitha RS; Roushan R; Rastogi A; Nair S; Diundi A; Raju MC; Joseph D; Gupta M
J Med Imaging Radiat Sci; 2023 Jun; 54(2):306-311. PubMed ID: 36868903
[TBL] [Abstract][Full Text] [Related]
16. Single-Center Prospective Trial Investigating the Feasibility of Serial FDG-PET Guided Adaptive Radiation Therapy for Head and Neck Cancer.
Gouw ZAR; La Fontaine MD; Vogel WV; van de Kamer JB; Sonke JJ; Al-Mamgani A
Int J Radiat Oncol Biol Phys; 2020 Nov; 108(4):960-968. PubMed ID: 32361007
[TBL] [Abstract][Full Text] [Related]
17. Clinical and dosimetric impact of adaptive intensity-modulated radiotherapy in locally advanced head-and-neck cancer.
Maheshwari G; Dhanawat A; Kumar HS; Sharma N; Jakhar SL
J Cancer Res Ther; 2020; 16(3):600-604. PubMed ID: 32719274
[TBL] [Abstract][Full Text] [Related]
18. MRI-guided radiotherapy for head and neck cancer: initial clinical experience.
Chen AM; Hsu S; Lamb J; Yang Y; Agazaryan N; Steinberg ML; Low DA; Cao M
Clin Transl Oncol; 2018 Feb; 20(2):160-168. PubMed ID: 28612199
[TBL] [Abstract][Full Text] [Related]
19. Comparison of unilateral versus bilateral intensity-modulated radiotherapy for surgically treated squamous cell carcinoma of the palatine tonsil.
Chin RI; Rao YJ; Hwang MY; Spencer CR; Pierro M; DeWees T; Patel P; Sinha P; Gay HA; Daly M; Haughey BH; Nussenbaum B; Adkins DR; Lewis JS; Thorstad WL
Cancer; 2017 Dec; 123(23):4594-4607. PubMed ID: 28881377
[TBL] [Abstract][Full Text] [Related]
20. Value of intensity-modulated radiotherapy in Stage IV head-and-neck squamous cell carcinoma.
Dirix P; Nuyts S
Int J Radiat Oncol Biol Phys; 2010 Dec; 78(5):1373-80. PubMed ID: 20362402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
